The P27 (cyclin‐dependent kinase inhibitor 1B) inhibits cyclin/cyclin‐dependent kinase (CDK) complexes and halts cell cycle progression and regulates invasion and migration of cancer cells, functioning as either an oncoprotein or a tumor suppressor (Currier et al., 2019). Here, CDKN1B is linked to cancer.